---
markmap:
  colorFreezeLevel: 6
---

# CMV (Cytomegalovirus)

## Virology
- DNA virus
- Betaherpesvirus
- Latency

## Transmission
- **Secretions:** Saliva, Urine, Semen, Cervical
- **Blood:** Transfusion
- **Transplant:** Organ, Stem Cell
- **Congenital:** In utero (TORCH)
- **Perinatal:** Birth canal, Breast milk

## Clinical Syndromes
- **Immunocompetent:**
  - Mononucleosis-like (Heterophile negative)
  - Hepatitis
- **Immunocompromised:**
  - **Transplant:**
    - Viremia (marker)
    - Organ-specific disease (Pneumonitis, GI, Retinitis, CNS)
    - Graft dysfunction
  - **HIV/AIDS (<50 CD4):**
    - Retinitis (High yield)
    - Colitis / Esophagitis (High yield)
    - Polyradiculopathy
    - Encephalitis
  - Others (Chemotherapy, etc.)
- **Congenital CMV:** (High yield)
  - **Symptomatic (~10%):**
    - **TORCH features**
    - **Neurological:** Microcephaly, Seizures, **Periventricular calcifications**, Intellectual disability
    - **Auditory:** **Sensorineural Hearing Loss (SNHL)** (most common long-term sequela)
    - **Hematologic:** Thrombocytopenia (petechiae), Anemia
    - **Hepatic:** Hepatosplenomegaly, Jaundice, Elevated LFTs
    - Ocular: Chorioretinitis
    - Growth Restriction
  - **Asymptomatic (~90%):**
    - Risk of late-onset **SNHL**
- **Perinatal:**
  - Mild/Asymptomatic
  - Pneumonitis (rare)

## Diagnosis
- **PCR:** (Viral load, Plasma, Whole blood, CSF, Tissue) - High yield for active disease
- **Serology:**
  - IgM (Recent infection, can be false positive/persistent)
  - IgG (Exposure)
  - Avidity (Acute vs. past primary infection in pregnancy)
- **Histology:**
  - **Owl's eye inclusions** (Cytoplasmic & nuclear) - High yield
- **Culture:** (Shell vial assay) - Slower, less common
- **Antigen Assays:** pp65 antigenemia - Historically important, less used vs PCR

## Treatment
- **First Line:**
  - **Ganciclovir** (IV)
  - **Valganciclovir** (Oral, prodrug)
- **Mechanism:** Inhibit viral DNA polymerase
- **Side Effects:** Myelosuppression (Neutropenia)
- **Second Line / Resistance:**
  - **Foscarnet:** (IV) - Renal toxicity, electrolyte imbalance
  - **Cidofovir:** (IV) - Nephrotoxicity
  - **Letermovir:** (Oral/IV) - Prophylaxis/treatment refractory in transplant

## Prevention / Prophylaxis
- **Antiviral Prophylaxis:** (Valganciclovir/Ganciclovir, Letermovir in transplant)
- **Pre-emptive Therapy:** Monitor viral load, treat when detected
- Screening blood products/organ donors
- Safe practices (Hygiene)

## INICET Buzzwords / High Yield
- **Owl's Eye Inclusions** (Histology)
- **Periventricular Calcifications** (Congenital CMV)
- **Sensorineural Hearing Loss (SNHL)** (Congenital/Perinatal CMV)
- **Ganciclovir / Valganciclovir** (First-line treatment)
- **Foscarnet** (Resistance, Renal toxicity)
- **Retinitis** (HIV, Transplant)
- **Colitis** (HIV)
- **pp65 antigenemia** (Diagnostic marker)
- **Heterophile Negative Mononucleosis** (Immunocompetent)
- **Transplant Recipients** (High risk population)
- **HIV <50 CD4** (High risk for severe disease)
- **TORCH infection** (Congenital)


